重庆零壹玖文化发展有限公司
20人以下
公司优势

20,861+ 岗位更新等你来订阅
一键订阅最新的岗位,每周送达
🎉恭喜你,订阅成功
继续订阅您可以在邮箱中随时取消订阅
目标感强,运用专业技能帮助客户解决问题。提升空间大,只要你肯努力,我们会提供发展环境,让你充分展示个人能力。
西安嘉铭实业有限公司诚聘
日立家用电梯湖南总代理
Bio-Thera Solutions, Ltd., headquartered in Guangzhou, China, is an international biopharmaceutical firm renowned for its scientific innovation. The company is committed to the development of cutting-edge therapeutics and biosimilar drugs aimed at addressing a wide array of medical challenges including cancer, autoimmune disorders, cardiovascular conditions, ophthalmological issues, and other life-threatening illnesses. As a pioneer in the realm of next-generation antibody drug research, Bio-Thera Solutions has driven several of its candidate drugs into advanced clinical stages of testing. Notably, the company's QLETLI? (Adalimumab), Prubece? (Bevacizumab), and Shuirili? (Tocilizumab) have received approval for commercialization in China, while TOFIDENCE? (Tocilizumab) and Avzivi? (Bevacizumab) have been authorized for use in both the US and China.
With a robust pipeline of over twenty investigational products at various stages of clinical development, Bio-Thera Solutions particularly emphasizes research in post-PD-1 era immunotherapy and the development of Antibody Drug Conjugates (ADCs) for targeted drug delivery. At the core of the company's mission is a commitment to patient welfare, driven by a dedication to innovating high-quality, safe, effective, and affordable treatments that address unmet medical needs.
For comprehensive details, please explore our official website or connect with us on Twitter and WeChat.
我司凭借多年深厚行业底蕴,将创新与杰出服务质量视为核心驱动力,全心全意为顾客提供顶级的产品与服务。作为行业内的领头羊,我们始终坚持客户为中心的原则,通过持续的技术革新与工艺优化,确保我司产品在市场中占据显著的竞争优势。